Heron Therapeutics, Inc.
HRTXBiotechnology
$0.29−4.69%As of Oct 29vs prior close
- Market cap
- $55.9M
- P/E (TTM)
- –
- From 52W high
- −80.24%
- EPS (LTM)
- -$0.18
- Revenue (LTM)
- $151.2M
- Net margin
- -22.52%
- Dividend yield
- 0.00%
Nomior Score
24
Steady ProfileSpeculativeBottom 10% of the scored universe
Growth35
Quality56
Value41
Momentum13
Resilience34
Growth
+70.40%revenue a year over 9 fiscal years
YE16 $1.3MLTM $151.2M
Connections
Revenue to profitQ2 YE26
The operating loss was 5% of revenue, wider by 1 pt on a year.
Who owns it
2funds